GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OSTO:RAY B) » Definitions » Current Ratio

RaySearch Laboratories AB (OSTO:RAY B) Current Ratio : 1.21 (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is RaySearch Laboratories AB Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. RaySearch Laboratories AB's current ratio for the quarter that ended in Mar. 2024 was 1.21.

RaySearch Laboratories AB has a current ratio of 1.21. It generally indicates good short-term financial strength.

The historical rank and industry rank for RaySearch Laboratories AB's Current Ratio or its related term are showing as below:

OSTO:RAY B' s Current Ratio Range Over the Past 10 Years
Min: 0.99   Med: 1.71   Max: 4.43
Current: 1.21

During the past 13 years, RaySearch Laboratories AB's highest Current Ratio was 4.43. The lowest was 0.99. And the median was 1.71.

OSTO:RAY B's Current Ratio is ranked worse than
57.88% of 679 companies
in the Healthcare Providers & Services industry
Industry Median: 1.37 vs OSTO:RAY B: 1.21

RaySearch Laboratories AB Current Ratio Historical Data

The historical data trend for RaySearch Laboratories AB's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB Current Ratio Chart

RaySearch Laboratories AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.63 1.35 1.00 0.99 1.19

RaySearch Laboratories AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.06 1.08 1.21 1.19 1.21

Competitive Comparison of RaySearch Laboratories AB's Current Ratio

For the Health Information Services subindustry, RaySearch Laboratories AB's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB's Current Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Current Ratio distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Current Ratio falls into.



RaySearch Laboratories AB Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

RaySearch Laboratories AB's Current Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Current Ratio (A: Dec. 2023 )=Total Current Assets (A: Dec. 2023 )/Total Current Liabilities (A: Dec. 2023 )
=802.446/675.049
=1.19

RaySearch Laboratories AB's Current Ratio for the quarter that ended in Mar. 2024 is calculated as

Current Ratio (Q: Mar. 2024 )=Total Current Assets (Q: Mar. 2024 )/Total Current Liabilities (Q: Mar. 2024 )
=903.163/745.892
=1.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RaySearch Laboratories AB  (OSTO:RAY B) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


RaySearch Laboratories AB Current Ratio Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


RaySearch Laboratories AB (OSTO:RAY B) Business Description

Traded in Other Exchanges
Address
Sveavagen 44, P.O. Box 3297, Stockholm, SWE, 103 65
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.

RaySearch Laboratories AB (OSTO:RAY B) Headlines

No Headlines